Case Study: a pharmaceutical company cuts batch time and boosts bioprocess control with Catalyx OpenBIO and Endress+Hauser Raman analyzers

Pharmaceutical Company - Customer Case Study

A pharmaceutical company faced challenges with manual sampling for its bioreactors, which led to inefficiencies, contamination risks, and an inability to leverage real-time process data. To overcome these barriers to adopting Process Analytical Technology (PAT), the company partnered with vendor Catalyx and implemented their OpenBIO® Open Architecture Bioreactor Controller.

Catalyx integrated their OpenBIO system with over 30 Endress+Hauser Raman analyzers to enable automated, real-time monitoring and control of the bioprocess. This solution eliminated manual sampling, reduced batch processing time from seven days to three, and delivered an estimated annual ROI of $300,000 per unit. Catalyx's technology allowed the company to optimize production and ensure consistent quality for FDA-approved products.